Give pharmaceutical execs the benefit of doubt — but they need to work for it
Director of the Center for Integration of Science and Industry Fred Ledley authors a piece highlighting research from the Center that suggests the pharmaceutical industry should be able to preserve both corporate profits and a pipeline of new products.